Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BtuG2 is a surface-exposed lipoprotein found in Bacteroides species from the human gut microbiome, where it is involved in scavenging vitamin B12 (cobalamin) and related corrinoids from the environment[2][4][5]. BtuG2 forms a stable complex with the TonB-dependent transporter BtuB2 in the bacterial outer membrane, acting as an extracellular lid and enabling efficient transport of B12 into the cell[1]. It adopts a seven-bladed beta-propeller fold, with a central cavity forming the binding site for corrinoids, including cobalamin and its analogs[1]. BtuG2 binds vitamin B12 with extremely high (femtomolar) affinity, enabling Bacteroides to acquire this vital cofactor from complexed or host-bound sources such as intrinsic factor[2]. This protein is crucial for microbial fitness in competitive gut environments, but is not recognized as a therapeutic target, enzyme, or receptor in human medicine[2]. No direct drug interactions, mechanisms of action, or biomarker data related to BtuG2 are reported in the scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BtuG2 lipoprotein (BtuG2).